Oncology Precision Medicine Market
Table of Contents
Global Oncology Precision Medicine Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Oncology Precision Medicine Market by Value
2.2.1 Global Oncology Precision Medicine Revenue by Type
2.2.2 Global Oncology Precision Medicine Market by Value
2.3 Global Oncology Precision Medicine Market by Sales
2.3.1 Global Oncology Precision Medicine Sales by Type
2.3.2 Global Oncology Precision Medicine Market by Sales
3. The Major Driver of Oncology Precision Medicine Industry
3.1 Historical & Forecast Global Oncology Precision Medicine Sales and Revenue (2018-2028)
3.2 Largest Application for Oncology Precision Medicine (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Oncology Precision Medicine Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Oncology Precision Medicine Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Oncology Precision Medicine Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Oncology Precision Medicine Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Oncology Precision Medicine Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Oncology Precision Medicine Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Oncology Precision Medicine Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Oncology Precision Medicine Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Oncology Precision Medicine Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Oncology Precision Medicine Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Oncology Precision Medicine Average Price Trend
13.1 Market Price for Each Type of Oncology Precision Medicine in US (2018-2022)
13.2 Market Price for Each Type of Oncology Precision Medicine in Europe (2018-2022)
13.3 Market Price for Each Type of Oncology Precision Medicine in China (2018-2022)
13.4 Market Price for Each Type of Oncology Precision Medicine in Japan (2018-2022)
13.5 Market Price for Each Type of Oncology Precision Medicine in India (2018-2022)
13.6 Market Price for Each Type of Oncology Precision Medicine in Korea (2018-2022)
13.7 Market Price for Each Type of Oncology Precision Medicine in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Oncology Precision Medicine in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Oncology Precision Medicine Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Oncology Precision Medicine
15. Oncology Precision Medicine Competitive Landscape
15.1 Abbott Laboratories
15.1.1 Abbott Laboratories Company Profiles
15.1.2 Abbott Laboratories Product Introduction
15.1.3 Abbott Laboratories Oncology Precision Medicine Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Agilent Technologies
15.2.1 Agilent Technologies Company Profiles
15.2.2 Agilent Technologies Product Introduction
15.2.3 Agilent Technologies Oncology Precision Medicine Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Almac
15.3.1 Almac Company Profiles
15.3.2 Almac Product Introduction
15.3.3 Almac Oncology Precision Medicine Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 ANGLE plc
15.4.1 ANGLE plc Company Profiles
15.4.2 ANGLE plc Product Introduction
15.4.3 ANGLE plc Oncology Precision Medicine Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Asuragen
15.5.1 Asuragen Company Profiles
15.5.2 Asuragen Product Introduction
15.5.3 Asuragen Oncology Precision Medicine Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 BGI Group
15.6.1 BGI Group Company Profiles
15.6.2 BGI Group Product Introduction
15.6.3 BGI Group Oncology Precision Medicine Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Bio-Rad Laboratories
15.7.1 Bio-Rad Laboratories Company Profiles
15.7.2 Bio-Rad Laboratories Product Introduction
15.7.3 Bio-Rad Laboratories Oncology Precision Medicine Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 BioM?rieux
15.8.1 BioM?rieux Company Profiles
15.8.2 BioM?rieux Product Introduction
15.8.3 BioM?rieux Oncology Precision Medicine Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Bristol Myers Squibb
15.9.1 Bristol Myers Squibb Company Profiles
15.9.2 Bristol Myers Squibb Product Introduction
15.9.3 Bristol Myers Squibb Oncology Precision Medicine Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Roche Holding AG
15.10.1 Roche Holding AG Company Profiles
15.10.2 Roche Holding AG Product Introduction
15.10.3 Roche Holding AG Oncology Precision Medicine Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 Gilead Sciences
15.12 Illumina
15.13 Konica Minolta
15.14 LabCorp
15.15 MDxHealth
15.16 Myriad Genetics
15.17 Novartis
15.18 OPKO Health
15.19 Pacific Biosciences
15.20 Quest Diagnostics
15.21 Qiagen
16. Conclusion
17. Methodology and Data Source
List of Tables and Figures
Figure 1. Total Sales by Application of Oncology Precision Medicine Industry (Volume)
Figure 2. Oncology Precision Medicine Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Oncology Precision Medicine Revenue in 2022
Figure 5. US Oncology Precision Medicine Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Oncology Precision Medicine Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Oncology Precision Medicine Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Oncology Precision Medicine Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Oncology Precision Medicine Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Oncology Precision Medicine Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Oncology Precision Medicine Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Oncology Precision Medicine Revenue, by Type (Million USD) (2018-2028)
Table 4. Oncology Precision Medicine Sales, by Type (K Unit) (2018-2028)
Table 5. Oncology Precision Medicine Sales (K Unit) by Application (2018-2028)
Table 6. Oncology Precision Medicine Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Oncology Precision Medicine Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Oncology Precision Medicine Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Oncology Precision Medicine Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Oncology Precision Medicine Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Oncology Precision Medicine Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Oncology Precision Medicine Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Oncology Precision Medicine Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Oncology Precision Medicine Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Oncology Precision Medicine in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Oncology Precision Medicine in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Oncology Precision Medicine in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Oncology Precision Medicine in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Oncology Precision Medicine in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Oncology Precision Medicine in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Oncology Precision Medicine in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Abbott Laboratories Profiles
Table 61. Abbott Laboratories Oncology Precision Medicine Product Introduction
Table 62. Abbott Laboratories Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Abbott Laboratories Strategic initiatives
Table 64. Agilent Technologies Profiles
Table 65. Agilent Technologies Oncology Precision Medicine Product Introduction
Table 66. Agilent Technologies Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Agilent Technologies Strategic initiatives
Table 68. Almac Profiles
Table 69. Almac Oncology Precision Medicine Product Introduction
Table 70. Almac Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Almac Strategic initiatives
Table 72. ANGLE plc Profiles
Table 73. ANGLE plc Oncology Precision Medicine Product Introduction
Table 74. ANGLE plc Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. ANGLE plc Strategic initiatives
Table 76. Asuragen Profiles
Table 77. Asuragen Oncology Precision Medicine Product Introduction
Table 78. Asuragen Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Asuragen Strategic initiatives
Table 80. BGI Group Profiles
Table 81. BGI Group Oncology Precision Medicine Product Introduction
Table 82. BGI Group Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. BGI Group Strategic initiatives
Table 84. Bio-Rad Laboratories Profiles
Table 85. Bio-Rad Laboratories Oncology Precision Medicine Product Introduction
Table 86. Bio-Rad Laboratories Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Bio-Rad Laboratories Strategic initiatives
Table 88. BioM?rieux Profiles
Table 89. BioM?rieux Oncology Precision Medicine Product Introduction
Table 90. BioM?rieux Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. BioM?rieux Strategic initiatives
Table 92. Bristol Myers Squibb Profiles
Table 93. Bristol Myers Squibb Oncology Precision Medicine Product Introduction
Table 94. Bristol Myers Squibb Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Bristol Myers Squibb Strategic initiatives
Table 97. Roche Holding AG Profiles
Table 98. Roche Holding AG Oncology Precision Medicine Product Introduction
Table 99. Roche Holding AG Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Roche Holding AG Strategic initiatives
Table 101. Gilead Sciences Profiles
Table 102. Gilead Sciences Oncology Precision Medicine Product Introduction
Table 103. Gilead Sciences Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Gilead Sciences Strategic initiatives
Table 105. Illumina Profiles
Table 106. Illumina Oncology Precision Medicine Product Introduction
Table 107. Illumina Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. Illumina Strategic initiatives
Table 109. Konica Minolta Profiles
Table 110. Konica Minolta Oncology Precision Medicine Product Introduction
Table 111. Konica Minolta Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 112. Konica Minolta Strategic initiatives
Table 113. LabCorp Profiles
Table 114. LabCorp Oncology Precision Medicine Product Introduction
Table 115. LabCorp Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 116. LabCorp Strategic initiatives
Table 117. MDxHealth Profiles
Table 118. MDxHealth Oncology Precision Medicine Product Introduction
Table 119. MDxHealth Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 120. MDxHealth Strategic initiatives
Table 121. Myriad Genetics Profiles
Table 122. Myriad Genetics Oncology Precision Medicine Product Introduction
Table 123. Myriad Genetics Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 124. Myriad Genetics Strategic initiatives
Table 125. Novartis Profiles
Table 126. Novartis Oncology Precision Medicine Product Introduction
Table 127. Novartis Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 128. Novartis Strategic initiatives
Table 129. OPKO Health Profiles
Table 130. OPKO Health Oncology Precision Medicine Product Introduction
Table 131. OPKO Health Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 132. OPKO Health Strategic initiatives
Table 133. Pacific Biosciences Profiles
Table 134. Pacific Biosciences Oncology Precision Medicine Product Introduction
Table 135. Pacific Biosciences Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 136. Pacific Biosciences Strategic initiatives
Table 137. Quest Diagnostics Profiles
Table 138. Quest Diagnostics Oncology Precision Medicine Product Introduction
Table 139. Quest Diagnostics Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 140. Quest Diagnostics Strategic initiatives
Table 141. Qiagen Profiles
Table 142. Qiagen Oncology Precision Medicine Product Introduction
Table 143. Qiagen Oncology Precision Medicine Sales (Unit), Revenue (Million USD) (2018-2022)
Table 144. Qiagen Strategic initiatives
Industry Market Size
